Global Medical Polymer Market Report by Product, by Distribution Channel, by Gender, & by Region with Forecast 2017-2030

Market Overview

While working on new medical devices, engineers often need material or polymers for parts and devices to make new product i.e. functional and safe. While selecting the materials few parameters are kept in mind like cost, physical, chemical & biological properties of the material and regulatory concerns related to the material. Recently, few materials are on the watchlist of engineers, for instance, polyether ether ketone (PEEK), polyethylene and cyclic olefin copolymers (COCs), bioresorbables (polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL)) and fluoropolymers (polytetrafluoroethylene (PTFE), perfluoroether (PFA) and fluorinated ethylene propylene (FEP)) owing to their suitability for use in medical devices. The global medical polymers market size was estimated to growing at a CAGR of 8.12% over the forecast period. Growing home based health care demand, continuously growing pharmaceutical device demand, increasing elderly population and increasing medical need among them along with rapidly spreading chronic diseases, technological advancements, affordable home health care systems with alternative treatment methods, and government initiatives associated with the cause will steer the medical polymers market in the forecast timespan. Volatility in the petrochemical based raw materials price due to depleting petroleum reserves, fluctuating crude oil prices and strict regulations imposed by various medical agencies, WHO, FDA, REACH, etc. regarding the product quality and prices may pose a restraint on the global medical polymers market.

Medical Polymer Market Segmentation

By Product Type

• Medical Fibers & Resins (PVC, PP, PE, Polystyrene)

• Medical Elastomers (SBC, Rubber Latex)

• Biodegradable Medical Plastics

Medical fibers & resins include polyvinyl chloride (PVC), polypropylene (PP), polyethylene (PE), polystyrene (PS) and other thermoplastics and accounted to grow at over 7.67% CAGR, on the account of pervasiveness of cardiovascular issues, general medical conditions, infections, and other diseases, coupled with growing use of fibers and resins in spinal implants, cranial injuries, and hip and joint replacements, owing to benefits, such as improved biocompatibility and lower cost, over traditional materials.

By Application

• Medical Devices & Equipment

• Medical Packaging

• Others (cardio & tissue culture)

The demand for medical devices and equipment is expected to grow over the forecast period followed by packaging segment which is estimated to grow at a CAGR of 7.79% over the forecast period owing to its incorporation in the products, and medical disposable techniques.

By Geography

• North America (US, Canada) {Market Share (%), Market Size (USD Billion)} Medical Polymer Market

• Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion)} Medical Polymer Market

• Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of Middle East & Africa) {Market Share (%), Market Size (USD Billion)} Medical Polymer Market

• Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion)} Medical Polymer Market

• Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion)} Medical Polymer Market

• Rest of the World {Market Share (%), Market Size (USD Billion))} Medical Polymer Market

On the basis of region, North America dominated the global medical polymer market, owing to United States mature medical and pharmaceutical industry. While Europe tends to grow at the steady rate of 6.89% and will lose its share to APAC, Latin America and Middle East & Africa. Growing medical expenditure in China, India, Bangladesh, Indonesia, and Pakistan will encourage growth in Asia Pacific.

Covered In This Global Medical Polymer Market Report

The report covers the present ground scenario and the future growth prospects of the facility management market for 2017-2025 along with the market players’ analysis. We calculated the market size and revenue share on the basis of revenue generated from major players worldwide. Medical Polymer market is forecasted on the basis of revenue analysis, product benchmarking and strategic developments of key market players.

Medical Polymer Market Outlook 2017-2025, has been prepared based on an in-depth market analysis from industry experts. The report covers the competitive landscape and current position of major players in the medical polymer market space. The report also includes porter’s five force model, SWOT analysis, company profiling, business strategies of market players and their business models. “Medical Polymer Market Report” also recognizes value chain analysis to understand the cost differentiation, pricing models to provide competitive advantage to the existing and new entry players.

Key Market Players

Bayer AG

Evonik Industries

Celanese

DuPont

Dow Chemical

Eastman Chemical

Huntsman

Lubrizol

Ensinger

Trinseo

BASF

Arkema

Biomerics

DSM

Röchling.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

For a full detailed overview, send us the sample request.

Key questions answered in this Medical Polymer Market Report

• What is the total market size by 2025 and what would be the expected growth rate of market?

• What is the total revenue per segment and region in 2016-17 and what would be the expected revenue per segment and region over the forecast period?

• What are the key market trends?

• What are the factors which are driving this market?

• What are the major barriers to market growth?

• Who are the key vendors in this market space?

• What are the market opportunities for the existing and entry level players?

• What are the recent developments and business strategy of the key players?

Reasons to buy this market study

• Facilitate decision-making based on strong historic and forecast data for Medical Polymer Market

• Develop strategies based on the latest regulatory framework

• Position yourself to gain the maximum advantage of the Healthcare industry’s growth potential

• Identify key partners and business development avenues across the globe

• Respond to your competitors’ business structure, strategy and prospects

• Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market

• Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the medical plastics market

• Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders

• To strategically profile key players and comprehensively analyze their market shares and core competencies